Hsiehchen, D., Lohrey, J. H., Kainthla, R., Kazmi, S. M. A., Verma, N., Manwaring, C., Ahn, C., Zhu, H. (2026). Domvanalimab plus zimberelimab in unresectable and immunotherapy refractory biliary tract cancers: a phase 2 trial. Nature Communications. https://doi.org/10.1038/s41467-026-75554-z